To Assess the Impact of Ocular Allergy Treatment on Patients Using an Opthalmic Agent (or no Treatment) Versus Alcaftadine (Lastacaft)
Latest Information Update: 09 May 2019
At a glance
- Drugs Alcaftadine (Primary)
- Indications Allergic conjunctivitis; Rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms OAT-PIT
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Mar 2013 New trial record